electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in the U.K.
electroCore, Inc. (ECOR)
Last electrocore, inc. earnings: 3/23 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
BASKING RIDGE, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that England’s National Health Service (NHS) has exercised its option to extend the Innovation and Technology Payment (ITP) Program for the use of gammaCore in the treatment of cluster headache in adults. The extension will run through September 2020 and via this program, which started in April 2019, gammaCore will continue to be reimbursed for those patients in England who suffer from cluster headache and respond to our therapy. “We are pleased to have NHS England maintain their ITP program to fund and support bringing our gammaCore therapy to patients suffering from cluster headache. gammaCore remains the only device approved by the National Institute for Health and Care Excellence (NICE) for use in patients with drug resistant cluster headaches,” said Iain Strickland, VP of European Operations, electroCore, Inc. The ITP Pro
Show less
Read more
Impact Snapshot
Event Time:
ECOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECOR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECOR alerts
High impacting electroCore, Inc. news events
Weekly update
A roundup of the hottest topics
ECOR
News
- electroCore (NASDAQ:ECOR) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force AirmenGlobeNewswire
- electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswire
- electroCore Announces Third Quarter 2025 Financial ResultsGlobeNewswire
- electroCore (NASDAQ:ECOR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
ECOR
Earnings
- 11/5/25 - Miss
ECOR
Sec Filings
- 12/5/25 - Form 4
- 12/3/25 - Form 4
- 11/14/25 - Form 4
- ECOR's page on the SEC website